HAPLOIDENTICAL STEM CELL TRANSPLANTATION
Clinical trials for HAPLOIDENTICAL STEM CELL TRANSPLANTATION explained in plain language.
Never miss a new study
Get alerted when new HAPLOIDENTICAL STEM CELL TRANSPLANTATION trials appear
Sign up with your email to follow new studies for HAPLOIDENTICAL STEM CELL TRANSPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for sickle cell cure: drug may prevent transplant failure
⭐️ CURE ⭐️ Not yet recruitingThis study is testing if adding a drug called ruxolitinib to a stem cell transplant can help prevent the body from rejecting the new cells, which is a major risk. It aims to improve the chance of a cure for children and young adults with severe sickle cell disease. Up to 24 parti…
Matched conditions: HAPLOIDENTICAL STEM CELL TRANSPLANTATION
Phase: PHASE1, PHASE2 • Sponsor: University of Colorado, Denver • Aim: ⭐️ CURE ⭐️
Last updated Mar 12, 2026 13:50 UTC
-
Could a safer drug dose transform recovery after stem cell transplants?
Disease control Not yet recruitingThis study aims to see if using a lower dose of a powerful drug called cyclophosphamide after a stem cell transplant is just as effective as the standard higher dose. It will involve 180 adults with blood cancers who are receiving a transplant from a half-matched donor. The main …
Matched conditions: HAPLOIDENTICAL STEM CELL TRANSPLANTATION
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC